Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ATR | Q13535 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MITF | O75030 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7191379 | 0.83 | POLB (0.46) | POLBCYP1A2CYP2D6LMNAHPGD | |
| SCHEMBL7191381 | 0.83 | POLB (0.46) | POLBCYP1A2CYP2D6LMNAHPGD | |
| SCHEMBL30433465 | 0.82 | LMNA (0.58) | POLBCYP1A2CYP2D6LMNAHPGD | |
| SCHEMBL14553871 | 0.78 | POLB (0.49) | POLBCYP1A2CYP2D6LMNAHPGD | |
| SCHEMBL17914199 | 0.78 | POLB (0.50) | POLBCYP1A2CYP2D6LMNAHPGD | |
| SCHEMBL27165431 | 0.75 | LMNA (0.67) | POLBLMNAHPGDMEN1KMT2A | |
| SCHEMBL4942498 | 0.74 | POLB (0.50) | POLBCYP1A2CYP2D6GSK3BMEN1 | |
| SCHEMBL14553815 | 0.73 | POLB (0.57) | POLBCYP1A2CYP2D6GSK3BMEN1 | |
| SCHEMBL14552354 | 0.73 | POLB (0.46) | POLBCYP1A2CYP2D6MEN1KMT2A | |
| SCHEMBL14283993 | 0.73 | POLB (0.50) | POLBCYP1A2CYP2D6LMNAGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12109187-B2 | Antimicrobial compositions and related methods | WEST LIBERTY UNIVERSITY (US) | 2024-10-08 | — | — | US | disclosed |
| EP-4175937-A1 | A PROCESS FOR THE PREPARATION OF VANILLIN AND OTHER SUBSTITUTED PHENYLALDEHYDES | Council of Scientific and Industrial Research, an Indian Registered Body Incorporated under Regn. of Soc. Act (Act XXI of 1860) (IN) | 2023-05-10 | — | — | EP | disclosed |
| WO-2022032134-A9 | ANTIMICROBIAL COMPOSITIONS AND RELATED METHODS | WEST LIBERTY UNIVERSITY (US) | 2022-03-17 | — | — | WO | disclosed |
| US-20220040146-A1 | ANTIMICROBIAL COMPOSITIONS AND RELATED METHODS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-02-10 | — | — | US | disclosed |
| WO-2022032134-A1 | ANTIMICROBIAL COMPOSITIONS AND RELATED METHODS | WEST LIBERTY UNIVERSITY (US) | 2022-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12109187-B2 | Antimicrobial compositions and related methods | VCL, MGLL, LIPA | POLB 3580/4885CYP1A2 559/4885CYP2D6 754/4885 |
| US-20220040146-A1 | ANTIMICROBIAL COMPOSITIONS AND RELATED METHODS | VCL, MGLL, LIPA | POLB 3580/4885CYP1A2 559/4885CYP2D6 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.